1 |
Atherton, J. C., P. Cao, R. M. Peek, Jr., M. K. Tummuru, M. J. Blaserand and T. L. Cover. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific VacA types with cytotoxin pro duction and peptic ulceration. J. Biol. Chem. 270:17771-17777.
DOI
|
2 |
Bernet-Camard, M., V. Lievin, J. N. Brassart and A. Servin. 1997. The human Lactobacillus acidophilus strain LA1 secrets a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appli. Environ. Microbiol. 63(7):2747-2753.
|
3 |
Coconnier, M. H. and V. Lievin. 1998. Antagonistic activity against Helicobacter pylori infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Enviromental Microbiol. 64(11):4573-4580.
|
4 |
Cover, T. L. and M. J. Blaser. 1992. Helicobacter pylori and gastroduodenal disease. Ann. Rev. Med. 43:135-145.
DOI
ScienceOn
|
5 |
Cooper, K. E. The theory of antibiotic inhibition zone. 1964. In 'Analytical Microbiology' (Ed. F. Kavanaugh). Academic Press, Inc. New York. pp. 1-86.
|
6 |
Streekumar, O. and A. Hosono. 2001. Antimutagenic Properties fo Fermented Milk. Asian-Aust. J. Anim. Sci.14:218-231.
|
7 |
Songa, Y., N. Kato, C. Liua, Y. Matsumiyaa H. Katob and K. Watanabe. 2000. Rapid identification of 11 human intestinal lactobacillus species by multiplex PCR assays using groupe - and species -specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA. FEMS Micrbiol. Lett. 187(2):167-173.
|
8 |
Muehlenkamp-ulate, M. R. and J. J. Warthesen. 1999. Evaluation of Several Nonstarter Lactobacilli for Their Influence on Cheddar Cheese Slurry Proteolysis. J. Dairy Sci. 82:1370-1378.
ScienceOn
|
9 |
Fuller, R. 1991. Probiotics in human medicine. 32:439-442.
|
10 |
Pagliaccia, C., de M. Bernard, P. Luoetti, X. Ji, D. Burroni, T. L. Cover, E. Papini, R. Rappuoli, J. L. Telford and J. M. Reyrat. 1998. The m2 form of Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc. Natl Acad. Sci. USA. 95:10212-102278.
DOI
|
11 |
Alatossava, T. and A. T. Timiskajarvi. 1997. Development of oligonucleotide, primers from the 16S-23S r RNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR. Intrnational J. Food Microbiol. 35:49-56.
DOI
ScienceOn
|
12 |
Heatly, R. V. 1995. The Helicobacter Handbook, Blackwell Science Ltd.
|
13 |
Wendakoon, C. N., W. Fedio, A. Macleod and L. Ozimek. 1998. In vitro inhibition of Helicobacter pylori by dairy stater cultures. Milchwissenschaft. Milk science international. 53(9):499-502.
|
14 |
Gill, H. H. and H. G. Desai. 1993. J. Clinical Enterol. 16(1):6-9.
|
15 |
National Institute of Health. 1994. NIH Consensus Statement 12(1)
|
16 |
Kamiya, S., M. Kai, A. Ozawa, H. Kobayashi, T. Shirai, S. Harasawa and T. Miwa. 1994. Characteristics of vacuolating toxin produced by Helicobacter pylori. European J. Gastroenterology & Hepatology. 6(suppl. 1):S23-27.
|
17 |
Graham, D. Y., H. M. Malaty, D. G. Evans, D. J. Evans, P. D. Klein and E. Adam. 1991. Gastroenterol. 100:1495-1501.
|
18 |
Midolo, P. D., J. R. Lambert, R. Hull, F. Luo and M. L. Grayson. 1995. In vitro inhibition of Helicobacter pylori NCTC11637 by organic acid and lactic acid bacteria. J. applied bacteriol. (79):475-479.
|
19 |
Parker, R. B. 1974. Probiotics: The other half of the antibiotics story. Animal nutrition and Health. (29):4-8.
|
20 |
Leunk, R. D., P. T. Johnson and B. C. David. 1988. Cytotoxin activity in broth-culture filtrates of Campylobacter pylori. J. Med Microviol. 26(2):93-94.
DOI
|